ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

AACR honors Emil Frei III for pioneering work in childhood leukemia.

April 2, 2004

NCAB Votes No To Funding Diet FIT, Citing NCI Resources

December 8, 1989

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992

Herceptin Lowers Recurrence In Early Breast Cancer

November 25, 2005

Funding opportunities listed.

May 28, 2004

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990